abstract |
The present invention relates to substituted cyclodextrins and their pharmaceutically acceptable salts, pharmaceutical compositions, kits of parts and their use as coagulation promoters. The present invention also relates to methods of antagonizing the anticoagulant effect of an anticoagulant in a subject, methods for reducing or preventing bleeding in a subject, and methods for treating or preventing blood clotting disorders. |